S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

LEGN Legend Biotech Corporation

44.915

-0.605 (-1.33%)

Last Updated: 00:22:19

Delayed by 15 minutes

Form 144/A - Report of proposed sale of securities: [Amend]

Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Legend Biotech Charts.

Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Legend Biotech Charts.

Legend Biotech Corporation News

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Tuesday 23 April 2024 (3 weeks ago) • Business Wire

Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
Thursday 11 April 2024 (4 weeks ago) • Business Wire

Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma
Saturday 6 April 2024 (1 month ago) • Business Wire

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report
Tuesday 19 March 2024 (2 months ago) • Business Wire

CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Saturday 16 March 2024 (2 months ago) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Legend Biotech Reports Fourth Quarter and Full Year 2023 Results and Recent Highlights
Monday 11 March 2024 (2 months ago) • Business Wire

U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher
Monday 11 March 2024 (2 months ago) • IH Market News

Form 144/A - Report of proposed sale of securities: [Amend]
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 24 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 23 February 2024 (3 months ago) • Edgar (US Regulatory)

More Legend Biotech Corporation News Articles

Westpac Banking

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions